ERBB2 and neoplasm: Inhibition of AKT1 in MMTV-ErbB2/neu and MMTV-PyMT-induced mouse mammary tumors results in diminished tumor development due to lower expression of Ki-67 and cyclin D and increased apoptosis [38].